Kenneth D. Swenerton

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Karen A. Gelmon, Marc Tischkowitz, Helen Mackay et al. · The Lancet Oncology · 2011 · 1.1K citations

Breast Oncology, Medicine, Gynecology +9

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine · 2008 · 812 citations · Full text

Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary

Sohrab P. Shah, Martin Köbel, Janine Senz et al. · New England Journal of Medicine · 2009 · 756 citations · Full text

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

Elizabeth A. Eisenhauer, W.W. ten Bokkel Huinink, Kenneth D. Swenerton et al. · Journal of Clinical Oncology · 1994 · 640 citations

Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas

Martin Köbel, Steve E. Kalloger, David G. Huntsman et al. · International Journal of Gynecological Pathology · 2010 · 395 citations

Tumoral Pathology, Gynecological Surgery, Ovarian Carcinomas +10